Skip to content
GLP-1 Decoder

Kansas Medicaid GLP-1 Coverage: Wegovy, Zepbound

Yes. Kansas Medicaid covers GLP-1s for weight loss. KanCare covers anti-obesity GLP-1s, including Foundayo, Wegovy, Zepbound and Saxenda, with prior authorization and a baseline weight and BMI.

For weight loss
Covered with prior authorization
For type 2 diabetes
Covered
Prior authorization is Needed
Weight loss, KFF survey January 2026
Covered

Does Kansas Medicaid cover GLP-1s?

The listed sources are kdhe.ks.gov, KFF.

Every drug: Wegovy, Zepbound, Ozempic, Mounjaro

GLP-1 drugs in Kansas Medicaid
MedicineMain useIn Kansas MedicaidEvery state
WegovyWeight lossCovered with prior authorizationWegovy and Medicaid
ZepboundWeight lossCovered with prior authorizationZepbound and Medicaid
FoundayoWeight lossCovered with prior authorizationNot listed
SaxendaWeight lossCovered with prior authorizationSaxenda and Medicaid
OzempicType 2 diabetesCovered for type 2 diabetesOzempic and Medicaid
MounjaroType 2 diabetesCovered for type 2 diabetesMounjaro and Medicaid
RybelsusType 2 diabetesCovered for type 2 diabetesRybelsus and Medicaid
TrulicityType 2 diabetesCovered for type 2 diabetesTrulicity and Medicaid
VictozaType 2 diabetesCovered for type 2 diabetesVictoza and Medicaid

The listed sources are kdhe.ks.gov.

Prior authorization rules

Source: kdhe.ks.gov.

How to check your plan

  1. Look for the drug on the state list: Kansas Medicaid drug list.
  2. If a managed care plan runs your Medicaid, call the member number on your card and ask whether the drug needs prior authorization.
  3. Preferred drugs get approved faster, so ask your prescriber which GLP-1 is preferred.
  4. The approval or denial notice states the rule that applies to you, so keep it.

Which brand pages apply in Kansas

If Kansas Medicaid says no

If coverage says no
MedicineLowest self-payManufacturer offer when your plan does not cover it
Wegovy$149 a monthNot listed
Zepbound$299 a month$299 a month
Foundayo$149 a monthNot listed

Sources: foundayo.lilly.com, TrumpRx, NovoCare, CMS.